机译:透视:阿尔茨海默病生物标志物二分法分类的临床相关性:应该有一个“灰色区域”吗?
Department of Infectious Disease EpidemiologySchool of Public Health Imperial College LondonLondon;
Ageing Epidemiology (AGE) Research UnitSchool of Public Health Imperial College LondonLondon;
Ageing Epidemiology (AGE) Research UnitSchool of Public Health Imperial College LondonLondon;
Department of Infectious Disease EpidemiologySchool of Public Health Imperial College LondonLondon;
Ageing Epidemiology (AGE) Research UnitSchool of Public Health Imperial College LondonLondon;
Bioclinica Inc.Newark CA USA;
Department of Infectious Disease EpidemiologySchool of Public Health Imperial College LondonLondon;
Department of Infectious Disease EpidemiologySchool of Public Health Imperial College LondonLondon;
Bioclinica Inc.Lyon France;
Ageing Epidemiology (AGE) Research UnitSchool of Public Health Imperial College LondonLondon;
Department of Infectious Disease EpidemiologySchool of Public Health Imperial College LondonLondon;
Department of Infectious Disease EpidemiologySchool of Public Health Imperial College LondonLondon;
Ageing Epidemiology (AGE) Research UnitSchool of Public Health Imperial College LondonLondon;
Department of Infectious Disease EpidemiologySchool of Public Health Imperial College LondonLondon;
NIA‐AA; AT(N); Biomarker thresholds; Perithreshold; Amyloid PET; SUVR; Alzheimer's clinical syndrome; Cognitive decline; Alzheimer's disease Neuroimaging Initiative; ADNI;
机译:透视:阿尔茨海默病生物标志物二分法分类的临床相关性:应该有一个“灰色区域”吗?
机译:阿尔茨海默氏生物标志物和临床阿尔茨海默氏病与记忆性临床人群中脑血管疾病的增加无关
机译:通过分析阿尔茨海默病患者疾病临床试验的临床终点和生物标志物之间的联系,支持疾病修饰疗法
机译:使用数据挖掘分类方法预测SNP生物标志物和临床数据的阿尔茨海默氏病:决策树
机译:临床诊断的阿尔茨海默病的成像遗传学和生物标志物变异
机译:结合多种分子生物标记物进行二分类诊断的简单方法
机译:卷积神经网络的阿尔茨海默病的疾病分类采用杂交增强的独立分量分析基于T2加权磁共振成像的分段灰质,具有临床估值